Burjeel Holdings (Burjeel), a leading super-specialty healthcare services provider in Mena listed on the Abu Dhabi Securities Exchange (ADX), on Thursday announced its financial results in accordance with International Financial Reporting Standards (IFRS) for the twelve-month period ended Dec.31, 2023.

Revenue grew by 15.6 per cent to Dhs4.5 billion, driven by higher patient footfall coupled with stronger patient yield. EBITDA reached Dhs1.0 billion, an increase of 17.7 per cent, reflecting the ramp-up of growth assets.

Net profit rose by 52.4 per cent to Dhs540 million, reflecting robust top-line growth and finance costs optimisation.

Dr Shamsheer Vayalil, Founder and Non-Executive Chairman of Burjeel Holdings, commented: “Burjeel is playing an increasing role in these improvements by providing world-class healthcare for the Gulf. During the year, we continued to form and nurture enduring partnerships with the world’s leading institutions, research organizations, and medical practitioners. These partnerships are vital in accelerating the development of complex healthcare in fields such as oncology, transplants, genetics, fetal medicine, neuroscience, sports medicine and advanced rehab. We cared for more than six million patients and achieved high patient satisfaction scores across our facilities.

Burjeel Holdings saw remarkable progress on its strategic ambitions to ramp up the Group’s high-growth assets, expand its healthcare infrastructure and drive patient yield through the provision of highly specialised complex care.